nach oben

Erschienen in:

06.10.2016 | Original Article

Epigenome-wide DNA methylation analysis in siblings and monozygotic twins discordant for sporadic Parkinson’s disease revealed different epigenetic patterns in peripheral blood mononuclear cells

verfasst von: Oliver Kaut, Ina Schmitt, Jörg Tost, Florence Busato, Yi Liu, Per Hofmann, Stephanie H. Witt, Marcella Rietschel, Holger Fröhlich, Ullrich Wüllner

Erschienen in: Neurogenetics | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Abstract

Numerous studies have elucidated the genetics of Parkinson’s disease; however, the aetiology of the majority of sporadic cases has not yet been resolved. We hypothesized that epigenetic variations could be associated with PD and evaluated the DNA methylation pattern in PD patients compared to brothers or twins without PD. The methylation of DNA from peripheral blood mononuclear cells of 62 discordant siblings including 24 monozygotic twins was characterized with Illumina DNA Methylation 450K bead arrays and subsequently validated in two independent cohorts: 221 PD vs. 227 healthy individuals (cohort 1) applying Illumina’s VeraCode and 472 PD patients vs. 487 controls (cohort 2) using pyrosequencing. We choose a delta beta of >15 % and selected 62 differentially methylated CpGs in 51 genes from the discordant siblings. Among them, three displayed multiple CpGs per gene: microRNA 886 (MIR886, 10 CpGs), phosphodiesterase 4D (PDE4D, 2 CpGs) and tripartite motif-containing 34 (TRIM34, 2 CpGs). PDE4D was confirmed in both cohorts (p value 2.44e−05). In addition, for biomarker construction, we used the penalized logistic regression model, resulting in a signature of eight CpGs with an AUC of 0.77. Our findings suggest that a distinct level of PD susceptibility stems from individual, epigenetic modifications of specific genes. We identified a signature of CpGs in blood cells that could separate control from disease with a reasonable discriminatory power, holding promise for future epigenetically based biomarker development.

Sharma M, Ioannidis JP, Aasly JO, Annesi G, Brice A, Van Broeckhoven C (2012) Large-scale replication and heterogeneity in Parkinson disease genetic loci. Neurology 79:659–667CrossRefPubMedPubMedCentral

Nalls MA, Pankratz N, Lill CM et al (2014) Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson’s disease. Nat Genet 46:989–993CrossRefPubMedPubMedCentral

Wirdefeldt K, Gatz M, Reynolds CA, Prescott CA, Pedersen NL (2011) Heritability of Parkinson disease in Swedish twins: a longitudinal study. Neurobiol Aging 32:1923.e1–1923.e8CrossRef

Christensen BC, Houseman EA, Marsit CJ et al (2009) Aging and environmental exposures alter tissue-specific DNA methylation dependent upon CpG island context. PLoS Genet 14:e1000602CrossRef

Fraga MF, Esteller M (2007) Epigenetics and aging: the targets and the marks. Trends Genet 14:413–418CrossRef

Portela A, Esteller M (2010) Epigenetic modifications and human disease. Nat Biotechnol 28:1057–1068CrossRefPubMed

Fraga MF, Ballestar E, Paz MF et al (2005) Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci U S A 102:10604–10609CrossRefPubMedPubMedCentral

Bell JT, Spector TD (2012) DNA methylation sudies using twins: what are they telling us? Genome Biol 13:172CrossRefPubMedPubMedCentral

Bell JT, Saffery R (2012) The value of twins in epigenetic epidemiology. Int J Epidemiol 41:140–150CrossRefPubMed

10.

Champagne FA (2010) Early adversity and developmental outcomes: interaction between genetics, epigenetics, and social experiences across the life span. Perspect Psychol Sci 5:564–574CrossRefPubMed

11.

Jirtle RL, Skinner MK (2007) Environmental epigenomics and disease susceptibility. Nat Rev Genet 8:253–262CrossRefPubMed

12.

Tobi EW, Goeman JJ, Monajemi R, Gu H, Putter H, Zhang Y (2014) DNA methylation signatures link prenatal famine exposure to growth and metabolism. Nat Commun 5:5592CrossRefPubMedPubMedCentral

13.

Hughes V (2014) Epigenetics: the sins of the father. Nature 507:22–24CrossRefPubMed

14.

Kaut O, Schmitt I, Wüllner U (2012) Genome-scale methylation analysis of Parkinson’s disease patients’ brains reveals DNA hypomethylation and increased mRNA expression of cytochrome P450 2E1. Neurogenetics 13:87–91CrossRefPubMed

15.

Touleimat N, Tost J (2012) Complete pipeline for Infinium ((R)) Human Methylation 450K BeadChip data processing using subset quantile normalization for accurate DNA methylation estimation. Epigenomics 4:325–341CrossRefPubMed

16.

Price ME, Cotton AM, Lam LL, Farré P, Emberly E, Brown CJ, Robinson WP, Kobor MS (2013) Additional annotation enhances potential for biologically-relevant analysis of the Illumina Infinium HumanMethylation450 BeadChip array. Epigenetics Chromatin 6:4CrossRefPubMedPubMedCentral

17.

Du P, Kibbe WA, Lin SM (2008) lumi: a pipeline for processing Illumina microarray. Bioinformatics 24:1547–1548CrossRefPubMed

18.

Chen YA, Lemire M, Choufani S, Butcher DT, Grafodatskaya D, Zanke BW, Gallinger S, Hudson TJ, Weksberg R (2013) Discovery of cross-reactive probes and polymorphic CpGs in the Illumina Infinium HumanMethylation450 microarray. Epigenetics 8:203–209CrossRefPubMedPubMedCentral

19.

Houseman EA, Accomando WP, Koestler DC, Christensen BC, Marsit CJ, Nelson HH, Wiencke JK, Kelsey KT (2012) DNA methylation arrays as surrogate measures of cell mixture distribution. BMC Bioinformatics. doi:10.1186/1471-2105-13-86

20.

Zaykin DV (2011) Optimally weighted Z-test is a powerful method for combining probabilities in meta-analysis. J Evol Biol 24:1836–1841CrossRefPubMedPubMedCentral

21.

Maxx P, Horowitz J, Timothy Greenamyre J (2010) Mitochondrial iron metabolism and its role in neurodegeneration. J Alzheimers Dis 20(Suppl 2):S551–S568

22.

Rusconi L, Salvatoni L, Giudici L, Bertani I, Kilstrup-Nielsen C, Broccoli V (2008) CDKL5 expression is modulated during neuronal development and its subcellular distribution is tightly regulated by the C-terminal tail. J Biol Chem 283:30101–30111CrossRefPubMedPubMedCentral

23.

Imai Y, Soda M, Hatakeyama S, Akagi T, Hashikawa T, Nakayama KI, Takahashi R (2002) CHIP is associated with Parkin, a gene responsible for familial Parkinson’s disease, and enhances its ubiquitin ligase activity. Mol Cell 10:55–67CrossRefPubMed

24.

Du P, Zhang X, Huang CC, Jafari N, Kibbe WA, Hou L, Lin SM (2010) Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis. BMC Bioinformatics 11:587CrossRefPubMedPubMedCentral

25.

Friedman J, Hastie T, Tibshirani R (2010) Regularization paths for generalized linear models via coordinate descent. J Stat Softw 33:1–22CrossRefPubMedPubMedCentral

26.

Cedervall P, Aulabaugh A, Geoghegan KF, McLellan TJ, Pandit J (2015) Engineered stabilization and structural analysis of the autoinhibited conformation of PDE4. Proc Natl Acad Sci U S A 112:E1414–E1422PubMedPubMedCentral

27.

Yang L, Calingasan NY, Lorenzo BJ, Beal MF (2008) Attenuation of MPTP neurotoxicity by rolipram, a specific inhibitor of phosphodiesterase IV. Exp Neurol 211:311–314CrossRefPubMed

28.

Bate C, Williams A (2015) cAMP-inhibits cytoplasmic phospholipase A and protects neurons against amyloid-β-induced synapse damage. Biology (Basel) 4:591–606

29.

Hernán MA, Takkouche B, Caamaño-Isorna F, Gestal-Otero JJ (2002) A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson’s disease. Ann Neurol 52:276–284CrossRefPubMed

30.

Lin MK, Farrer MJ (2014) Genetics and genomics of Parkinson’s disease. Genome Med 6:48CrossRefPubMedPubMedCentral

31.

Coupland KG, Mellick GD, Silburn PA et al (2014) DNA methylation of the MAPT gene in Parkinson’s disease cohorts and modulation by vitamin E in vitro. Mov Disord 29:1606–1614CrossRefPubMed

32.

Ricciardi S, Ungaro F, Hambrock M (2012) CDKL5 ensures excitatory synapse stability by reinforcing NGL-1-PSD95 interaction in the postsynaptic compartment and is impaired in patient iPSC-derived neurons. Nat Cell Biol 14:911–923CrossRefPubMed

33.

Zhu YC, Li D, Wang L, Lu B, Zheng J, Zhao SL, Zeng R, Xiong ZQ (2013) Palmitoylation-dependent CDKL5-PSD-95 interaction regulates synaptic targeting of CDKL5 and dendritic spine development. Proc Natl Acad Sci U S A 110:9118–9123CrossRefPubMedPubMedCentral

34.

Mari F, Azimonti S, Bertani I et al (2005) CDKL5 belongs to the same molecular pathway of MeCP2 and it is responsible for the early-onset seizure variant of Rett syndrome. Hum. Mol Genet 14:1935–1946

35.

Imai Y, Soda M, Inoue H, Hattori N, Mizuno Y, Takahashi R (2001) An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin. Cell 105:891–902CrossRefPubMed

36.

Murakami T, Shoji M, Imai Y, Inoue H, Kawarabayashi T, Matsubara E, Harigaya Y, Sasaki A, Takahashi R, Abe K (2004) Pael-R is accumulated in Lewy bodies of Parkinson’s disease. Ann Neurol 55:439–442CrossRefPubMed

37.

Meyer RC, Giddens MM, Schaefer SA, Hall RA (2013) GPR37 and GPR37L1 are receptors for the neuroprotective and glioprotective factors prosaptide and prosaposin. Proc Natl Acad Sci U S A 110:9529–9534CrossRefPubMedPubMedCentral

38.

Rakyan VK, Down TA, Balding DJ, Beck S (2011) Epigenome-wide association studies for common human diseases. Nat Rev Genet 12:529–541CrossRefPubMedPubMedCentral

39.

Wüllner U, Klockgether T (2003) Inflammation in Parkinson’s disease. J Neurol 250 Suppl 1:I35–138CrossRefPubMed

40.

Chao Y, Wong, SC, Tan, EK (2014) Evidence of inflammatory system involvement in Parkinson’s disease. Biomed Res Int: 308654. Review

41.

Vivekanantham S, Shah S, Dewji R, Dewji A, Khatri C, Ologunde R (2015) Neuroinflammation in Parkinson’s disease: role in neurodegeneration and tissue repair. Int J Neurosci 125:717–725CrossRefPubMed

42.

Orimo A, Tominaga N, Yoshimura K, Yamauchi Y, Nomura M, Sato M, Nogi Y, Suzuki M, Suzuki H, Ikeda K, Inoue S, Muramatsu M (2000) Molecular cloning of ring finger protein 21 (RNF21)/interferon-responsive finger protein (ifp1), which possesses two RING-B box-coiled coil domains in tandem. Genomics 69:143–149CrossRefPubMed

43.

Rajsbaum R, Versteeg GA, Schmid S et al (2014) Unanchored K48-linked polyubiquitin synthesized by the E3-ubiquitin ligase TRIM6 stimulates the interferon-IKKε kinase-mediated antiviral response. Immunity 40:880–895CrossRefPubMedPubMedCentral

44.

Candel S, Sepulcre MP, Espín-Palazón R, Tyrkalska SD, de Oliveira S, Meseguer J, Mulero V (2015) Md1 and Rp105 regulate innate immunity and viral resistance in zebrafish. Dev Comp Immunol 50:155–165CrossRefPubMed

45.

Chen H, Jacobs E, Schwarzschild MA, McCullough ML, Calle EE, Thun M, Ascherio A (2005) Nonsteroidal antiinflammatory drug use and the risk for Parkinson’s disease. Ann Neurol 58:963–967CrossRefPubMed

46.

Eyal A, Szargel R, Avraham E, Liani E, Haskin J, Rott R, Engelender S (2006) Synphilin-1A: an aggregation-prone isoform of synphilin-1 that causes neuronal death and is present in aggregates from alpha-synucleinopathy patients. Proc Natl Acad Sci U S A 103:5917–5922CrossRefPubMedPubMedCentral

47.

Kaminsky ZA, Tang T, Wang SC, Ptak C, Oh GH, Wong AH (2009) DNA methylation profiles in monozygotic and dizygotic twins. Nat Genet 41:240–245CrossRefPubMed

48.

Mahishi LH, Hart RP, Lynch DR, Ratan RR (2012) miR-886-3p levels are elevated in Friedreich ataxia. J Neurosci 32:9369–9373CrossRefPubMedPubMedCentral

49.

Masliah E, Dumaop W, Galasko D, Desplats P (2013) Distinctive patterns of DNA methylation associated with Parkinson disease: identification of concordant epigenetic changes in brain and peripheral blood leukocytes. Epigenetics 8:1030–1038CrossRefPubMedPubMedCentral

50.

Davies MN, Volta M, Pidsley R (2012) Functional annotation of the human brain methylome identifies tissue-specific epigenetic variation across brain and blood. Genome Biol 13:R43CrossRefPubMedPubMedCentral

Titel: Epigenome-wide DNA methylation analysis in siblings and monozygotic twins discordant for sporadic Parkinson’s disease revealed different epigenetic patterns in peripheral blood mononuclear cells
verfasst von: Oliver Kaut
Ina Schmitt
Jörg Tost
Florence Busato
Yi Liu
Per Hofmann
Stephanie H. Witt
Marcella Rietschel
Holger Fröhlich
Ullrich Wüllner
Publikationsdatum: 06.10.2016
Verlag: Springer Berlin Heidelberg
Erschienen in: Neurogenetics / Ausgabe 1/2017
Print ISSN: 1364-6745
Elektronische ISSN: 1364-6753
DOI: https://doi.org/10.1007/s10048-016-0497-x

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Vierten reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Bluttest erkennt Parkinson schon zehn Jahre vor der Diagnose

10.05.2024 Parkinson-Krankheit Nachrichten

Ein Bluttest kann abnorm aggregiertes Alpha-Synuclein bei einigen Menschen schon zehn Jahre vor Beginn der motorischen Parkinsonsymptome nachweisen. Mit einem solchen Test lassen sich möglicherweise Prodromalstadien erfassen und die Betroffenen früher behandeln.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Wartezeit nicht kürzer, aber Arbeit flexibler

Psychotherapie Medizin aktuell

Fünf Jahren nach der Neugestaltung der Psychotherapie-Richtlinie wurden jetzt die Effekte der vorgenommenen Änderungen ausgewertet. Das Hauptziel der Novellierung war eine kürzere Wartezeit auf Therapieplätze. Dieses Ziel wurde nicht erreicht, es gab jedoch positive Auswirkungen auf andere Bereiche.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2017

DRD2 C957T polymorphism is associated with improved 6-month verbal learning following traumatic brain injury

Homozygous mutation, p.Pro304His, in IDH3A, encoding isocitrate dehydrogenase subunit is associated with severe encephalopathy in infancy

Erratum to: PARP10 deficiency manifests by severe developmental delay and DNA repair defect

SBF1 mutations associated with autosomal recessive axonal neuropathy with cranial nerve involvement

Mosaicism for a pathogenic MFN2 mutation causes minimal clinical features of CMT2A in the parent of a severely affected child